Why the study?
Few studies have correlated the mechanism of fetal bradycardia to pregnancy outcomes.
Does the mechanism of fetal bradycardia correlate with pregnancy and early postnatal outcomes?
Does the mechanism of fetal bradycardia correlate with pregnancy and early postnatal outcomes?
Fetal bradycardia has an overall favorable pregnancy outcome, and analyzing the specific arrhythmia mechanism helps guide prognostication and transplacental therapy decisions.
Answers are grounded in this paper and cite their sources.
Live-birth rates vary by fetal bradycardia mechanism; supports mechanism-based prognostication but remains hypothesis-generating for therapy.
Few studies have correlated the mechanism of fetal bradycardia to pregnancy outcomes. This study aimed to correlate the arrhythmia mechanism to pregnancy and early postnatal outcomes in fetal bradycardia. This was retrospective study (May 2013–November 2019). Fetuses with sustained bradycardia (heart rate ≤ 100 per minute) were included. Based on arrhythmia mechanism, patients were categorized into 4 groups:Group 1: blocked atrial ectopics, Group 2: second-degree atrioventricular block (AVB), Group 3: complete AVB and group 4: sinus bradycardia. Clinical presentation, need for transplacental therapy, pregnancy and early postnatal outcomes were analysed. A total of 36 patients were included. Mean gestational age was 26.2 ± 5.5 weeks. The most common arrhythmia mechanism was Group 3 (N = 24; 66.7%) followed by Group 2 (N = 5; 13.8%); groups 1 and 4 had 4 and 3 patients respectively. Maternal auto-antibodies were reported in 21 patients (58.3%); 19 were in Group 3. Transplacental therapy was needed in 15 (41.7%) cases; 14 were in Group 3. Live-birth was reported in 23 cases (63.9%), other outcomes included pregnancy termination (n = 7), intra-uterine death (n = 4) and lost to follow-up (n = 2). Live-births were most common in Groups 1 (100%) and 2 (80%), followed by Group 3 (54.2%). Postnatal mortality occurred in one patient (Group 2). Three patients (60%) in Group 2 had Long QT syndrome in postnatal evaluation. Eight patients (6 in group 3) needed pacemaker implantation after birth. Fetal bradycardia was associated with an overall favorable pregnancy and good early postnatal outcomes. Analysis of the arrhythmia mechanism should guide prognostication and decisions for transplacental therapy.
No takes yet. Share an insight, caveat, or question.
Lall et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: